These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12052712)

  • 1. Effects of PEG conjugation on insulin properties.
    Hinds KD; Kim SW
    Adv Drug Deliv Rev; 2002 Jun; 54(4):505-30. PubMed ID: 12052712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of poly(ethylene glycol)-insulin conjugates.
    Hinds K; Koh JJ; Joss L; Liu F; Baudys M; Kim SW
    Bioconjug Chem; 2000; 11(2):195-201. PubMed ID: 10725096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of monomethoxypoly(ethylene glycol)-insulin conjugates.
    Zhang M; Dou H; Yin L; Zhang Y; Zhu S; Yin C
    Pharmazie; 2009 Mar; 64(3):190-6. PubMed ID: 19348342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-induced release of glycosylpoly(ethylene glycol) insulin bound to a soluble conjugate of concanavalin A.
    Liu F; Song SC; Mix D; Baudys M; Kim SW
    Bioconjug Chem; 1997; 8(5):664-72. PubMed ID: 9327129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin at aqueous/organic interface.
    Taluja A; Bae YH
    Mol Pharm; 2007; 4(4):561-70. PubMed ID: 17439239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques.
    Elvassore N; Bertucco A; Caliceti P
    J Pharm Sci; 2001 Oct; 90(10):1628-36. PubMed ID: 11745721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Byproduct-Free Intact Modification of Insulin by Cholesterol End-Modified Poly(ethylene glycol) for in Vivo Protein Delivery.
    Asayama S; Nagashima K; Negishi Y; Kawakami H
    Bioconjug Chem; 2018 Jan; 29(1):67-73. PubMed ID: 29227638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vivo evaluation of an oral insulin-PEG delivery system.
    Calceti P; Salmaso S; Walker G; Bernkop-Schnürch A
    Eur J Pharm Sci; 2004 Jul; 22(4):315-23. PubMed ID: 15196588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylation of octreotide: II. Effect of N-terminal mono-PEGylation on biological activity and pharmacokinetics.
    Na DH; Lee KC; DeLuca PP
    Pharm Res; 2005 May; 22(5):743-9. PubMed ID: 15906169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and purification of mono-PEGylated insulin.
    Dou H; Zhang M; Zhang Y; Yin C
    Chem Biol Drug Des; 2007 Feb; 69(2):132-8. PubMed ID: 17381727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological properties of uricase conjugated to neutral soluble polymers.
    Caliceti P; Schiavon O; Veronese FM
    Bioconjug Chem; 2001; 12(4):515-22. PubMed ID: 11459455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins.
    Saifer MG; Williams LD; Sobczyk MA; Michaels SJ; Sherman MR
    Mol Immunol; 2014 Feb; 57(2):236-46. PubMed ID: 24200843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, physiochemical characterization, and in vitro antitumor activity of the amide and pH cleavable hydrazone conjugates of γ-tocotrienol isomer of vitamin E with methoxy-poly(ethylene) glycol.
    Abu-Fayyad A; Nazzal S
    Int J Pharm; 2017 Aug; 529(1-2):75-86. PubMed ID: 28627454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers.
    Mao S; Shuai X; Unger F; Wittmar M; Xie X; Kissel T
    Biomaterials; 2005 Nov; 26(32):6343-56. PubMed ID: 15913769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers.
    Zhu J; Zhou Z; Yang C; Kong D; Wan Y; Wang Z
    J Biomed Mater Res A; 2011 Jun; 97(4):498-508. PubMed ID: 21509931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-Domain deleted recombinant coagulation factor VIII modified with monomethoxy polyethylene glycol.
    Röstin J; Smeds AL; Akerblom E
    Bioconjug Chem; 2000; 11(3):387-96. PubMed ID: 10821655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin/poly(ethylene glycol)-block-poly(L-lysine) Complexes: Physicochemical Properties and Protein Encapsulation.
    Pippa N; Kalinova R; Dimitrov I; Pispas S; Demetzos C
    J Phys Chem B; 2015 Jun; 119(22):6813-9. PubMed ID: 25974620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypseudorotaxane formation of randomly-pegylated insulin with cyclodextrins: slow release and resistance to enzymatic degradation.
    Higashi T; Hirayama F; Misumi S; Motoyama K; Arima H; Uekama K
    Chem Pharm Bull (Tokyo); 2009 May; 57(5):541-4. PubMed ID: 19420793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squaric acid mediated chemoselective PEGylation of proteins: reactivity of single-step-activated α-amino poly(ethylene glycol)s.
    Dingels C; Wurm F; Wagner M; Klok HA; Frey H
    Chemistry; 2012 Dec; 18(52):16828-35. PubMed ID: 23135990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.